Cellular energy metabolism and longevity-adjacent research has become one of the fastest-growing areas of peptide and small-molecule research. Three compounds come up constantly in this space: NAD+, MOTS-c, and SLU-PP-332 — each approaching cellular energy pathways from a different angle.
NAD+
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell, central to redox reactions and energy metabolism. NAD+ levels are well documented to decline with age, which is the primary reason it anchors so much longevity-adjacent research — studies typically examine cofactor replenishment pathways and downstream effects on mitochondrial and metabolic function in model systems.
MOTS-c
MOTS-c is a mitochondrial-derived peptide, encoded within mitochondrial DNA itself rather than nuclear DNA — a relatively recent discovery in the broader field of "mitochondrial-derived peptides." Research interest centers on its apparent role in metabolic regulation and cellular stress response signaling, positioning it as a peptide-based complement to NAD+-focused research.
SLU-PP-332
SLU-PP-332 is a small-molecule ERR (estrogen-related receptor) agonist, studied for its role in metabolic regulation and mitochondrial activity through a nuclear receptor pathway rather than direct peptide signaling. It's frequently referenced in research examining exercise-mimetic and metabolic pathway activation.
Why these three overlap in research protocols
NAD+, MOTS-c, and SLU-PP-332 approach the same broad question — cellular energy and metabolic regulation — from three distinct mechanistic angles: cofactor biology, mitochondrial-derived peptide signaling, and nuclear receptor activation, respectively. That's exactly why they frequently appear together in comparative research designs.
Sourcing
All three are available with third-party purity and identity verification. Given the mechanistic differences between them, confirming you have the exact compound and concentration your protocol calls for is essential.